The chemical substance with the name "(2S)-4-[[4-[[1-(4,4-dimethyl-2,6-dioxo-cyclohexylidene)-3-methyl-butyl]amino]phenyl]methoxy]-2-(9H-fluoren-9-ylmethoxycarbonylamino)-4-oxo-butanoic acid" and CAS number "269066-08-2" is a complex organic compound characterized by its multi-functional structure. It features a butanoic acid backbone with various substituents, including an amino group and a methoxy group, which contribute to its potential biological activity. The presence of a fluorenylmethoxycarbonyl (Fmoc) group indicates its use in peptide synthesis and as a protecting group in organic synthesis. The compound's stereochemistry is specified by the (2S) designation, indicating a specific spatial arrangement of atoms that can influence its reactivity and interaction with biological targets. Additionally, the presence of a cyclohexylidene moiety suggests potential hydrophobic interactions, which may enhance its binding affinity in biological systems. Overall, this compound's intricate structure suggests it may have applications in medicinal chemistry, particularly in drug development or as a biochemical probe.

(2S)-4-[[4-[[1-(4,4-dimethyl-2,6-dioxo-cyclohexylidene)-3-methyl-butyl]amino]phenyl]methoxy]-2-(9H-fluoren-9-ylmethoxycarbonylamino)-4-oxo-butanoic acid

Please enquire for more information about Fmoc-L-aspartic acid beta-4-[N-{1-(4,4-dimethyl-2,6-dioxocyclohexylidene)-3-methylbutyl}amino]benzyl ester including the price, delivery time and more detailed product information at the technical inquiry form on this page

Fmoc-L-aspartic acid β-4-[N-{1-(4,4-dimethyl-2,6-dioxocyclohexylidene)-3-methylbutyl}amino]benzyl ester

FMOC-ASP(ODMAB)-OH

Dmab can be removed with 2% hydrazine in DMF generating an indazole which allows the UV-spectrophotometrical monitoring of the cleavage. Conroy et al. used this Asp derivative for the solid-phase synthesis of N-linked glycopeptides. As Dmab represents an unhindered  p-substituted Z-derivative, Asp(Dmab)-containing peptides are prone to base-catalyzed aspartimide formation.

CAS 269066-08-2: (2S)-4-[[4-[[1-(4,4-dimethyl-2,6-dioxo-cyclohexylidene)-3-methyl-butyl]amino]phenyl]methoxy]-2-(9H-fluoren-9-ylmethoxycarbonylamino)-4-oxo-butanoic acid

Fmoc-L-aspartic acid β-4-[N-{1-(4,4-dimethyl-2,6-dioxocyclohexylidene)-3-methylbutyl}amino]benzyl ester

Ref: 3D-FF55925

FMOC-ASP(ODMAB)-OH

Ref: IN-DA00BBP6

Fmoc-Asp(ODmab)-OH

Ref: 01-4028316